Université Libre de Bruxelles, Brussels, Belgium.
Br J Pharmacol. 2012 May;166(1):79-84. doi: 10.1111/j.1476-5381.2011.01616.x.
The vasoactive intestinal peptide receptor 1 (VPAC(1) ) belongs to family B of GPCRs and is activated upon binding of vasoactive intestinal peptide (VIP) and pituitary AC-activating polypeptide neuropeptides. Widely distributed throughout body, VPAC(1) plays important regulatory roles in human physiology and physiopathology. Like most members of the GPCR-B family, VPAC(1) receptor is predicted to follow the actual paradigm of a common 'two-domain' model of natural ligand action. However the precise structural basis for ligand binding, receptor activation and signal transduction are still incompletely understood due in part to the absence of X-ray crystal structure of the whole receptor and to significant structural differences with the most extensively studied family of receptor, the GPCR-A/rhodopsin family. Here, we try to summarize the current knowledge of the molecular mechanisms involved in VPAC(1) receptor activation and signal transduction. This includes search for amino acids involved in the two-step process of VIP binding, in the stabilization of VPAC(1) inactive and active conformations, and in binding and activation of G proteins.
血管活性肠肽受体 1(VPAC(1))属于 G 蛋白偶联受体家族 B,在结合血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽神经肽后被激活。VPAC(1)广泛分布于全身,在人体生理学和病理生理学中发挥着重要的调节作用。与大多数 G 蛋白偶联受体家族 B 成员一样,VPAC(1)受体被预测遵循天然配体作用的实际“双域”模型。然而,由于缺乏整个受体的 X 射线晶体结构,以及与研究最广泛的 G 蛋白偶联受体-A/视紫红质家族存在显著的结构差异,配体结合、受体激活和信号转导的确切结构基础仍不完全清楚。在这里,我们试图总结参与 VPAC(1)受体激活和信号转导的分子机制的最新知识。这包括寻找参与 VIP 结合的两步过程、稳定 VPAC(1)无活性和活性构象以及与 G 蛋白结合和激活的氨基酸。